Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-04-24
1991-07-30
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546112, A61K 3144
Patent
active
050360760
ABSTRACT:
Use of 2-azabicyclo[2.2.2]octane-3-carboxylic acid derivatives and their salts for the production of medicinal products intended for the treatment of arteritis and more especially arteritis of the lower limbs, disorders of the cerebral circulation and more especially disorders of cerebral senescence and migraine, and disorders of vision such as retinal disorders of vascular origin, diabetic retinopathy, chorioretinal atrophy and chorioretinal degeneration.
REFERENCES:
patent: 4397857 (1983-08-01), Vincent et al.
Chemical Abstracts, (100:210436f), 1984.
Chemical Abstracts, (111:97715h), 1989.
Th. Unger-Arzneim. Forschung Drug Research, 1984, (10b), 34(II), 1426-1430.
The Lancet, "Migraine: A Cerebral Disorder", Jul. 14, 1984, pp. 86-89.
Bayer UK Limited, Monograph, pp. 118-119.
Scholkens-Arzneim Forsch. Drug Research, 1984, (10b), 34(II), 1417-1425.
Adir et Compagnie
Hueschen Gordon W.
Waddell Frederick E.
Weddington Kevin E.
LandOfFree
Use of 2-azabicyclo[2.2.2]octane-3-carboxylic acid derivatives f does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of 2-azabicyclo[2.2.2]octane-3-carboxylic acid derivatives f, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of 2-azabicyclo[2.2.2]octane-3-carboxylic acid derivatives f will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1542834